메뉴 건너뛰기




Volumn 53, Issue 1, 2009, Pages 306-308

Testing of experimental compounds in a relapse model of tuberculosis using granulocyte-macrophage colony-stimulating factor gene-disrupted mice

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ISONIAZID; MOXIFLOXACIN; RIFAMPICIN;

EID: 59749105776     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01346-07     Document Type: Article
Times cited : (7)

References (29)
  • 2
    • 0014749044 scopus 로고
    • Rifampicin in the treatment of experimental tuberculosis in mice: Sterilization of tubercle bacilli in the tissues
    • Batten, J. 1970. Rifampicin in the treatment of experimental tuberculosis in mice: sterilization of tubercle bacilli in the tissues. Tubercle 51:95-99.
    • (1970) Tubercle , vol.51 , pp. 95-99
    • Batten, J.1
  • 3
    • 33846796149 scopus 로고    scopus 로고
    • Microbial phenotypic heterogeneity and antibiotic tolerance
    • Dhar, N., and J. D. McKinney. 2007. Microbial phenotypic heterogeneity and antibiotic tolerance. Curr. Opin. Microbiol. 10:30-38.
    • (2007) Curr. Opin. Microbiol , vol.10 , pp. 30-38
    • Dhar, N.1    McKinney, J.D.2
  • 6
    • 20044379240 scopus 로고    scopus 로고
    • Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection
    • Gonzalez-Juarrero, M., J. M. Hattle, A. Izzo, A. P. Junqueira-Kipnis, T. S. Shim, B. C. Trapnell, A. M. Cooper, and I. M. Orme. 2005. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J. Leukoc. Biol. 77:914-922.
    • (2005) J. Leukoc. Biol , vol.77 , pp. 914-922
    • Gonzalez-Juarrero, M.1    Hattle, J.M.2    Izzo, A.3    Junqueira-Kipnis, A.P.4    Shim, T.S.5    Trapnell, B.C.6    Cooper, A.M.7    Orme, I.M.8
  • 7
    • 0018121731 scopus 로고
    • The sterilizing value of rifampicin and pyrazinamide in experimental short-course chemotherapy
    • Grosset, J. 1978. The sterilizing value of rifampicin and pyrazinamide in experimental short-course chemotherapy. Tubercle 59:287-297.
    • (1978) Tubercle , vol.59 , pp. 287-297
    • Grosset, J.1
  • 8
    • 0029829728 scopus 로고    scopus 로고
    • Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis
    • Kelly, B. P., S. K. Furney, M. T. Jessen, and I. M. Orme. 1996. Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 40:2809-2812.
    • (1996) Antimicrob. Agents Chemother , vol.40 , pp. 2809-2812
    • Kelly, B.P.1    Furney, S.K.2    Jessen, M.T.3    Orme, I.M.4
  • 9
    • 18844368812 scopus 로고    scopus 로고
    • Bacterial persistence: A model of survival in changing environments
    • Kussell, E., R. Kishony, N. Q. Balaban, and S. Leibler. 2005. Bacterial persistence: a model of survival in changing environments. Genetics 169:1807-1814.
    • (2005) Genetics , vol.169 , pp. 1807-1814
    • Kussell, E.1    Kishony, R.2    Balaban, N.Q.3    Leibler, S.4
  • 10
    • 7544238351 scopus 로고    scopus 로고
    • Statistical limitations to the Cornell model of latent tuberculosis infection for the study of relapse rates
    • Lenaerts, A. J., P. L. Chapman, and I. M. Orme. 2004. Statistical limitations to the Cornell model of latent tuberculosis infection for the study of relapse rates. Tuberculosis (Edinburgh) 84:361-364.
    • (2004) Tuberculosis (Edinburgh) , vol.84 , pp. 361-364
    • Lenaerts, A.J.1    Chapman, P.L.2    Orme, I.M.3
  • 11
    • 0037310195 scopus 로고    scopus 로고
    • Lenaerts, A. J., V. Gruppo, J. V. Brooks, and I. M. Orme. 2003. Rapid in vivo screening of experimental drugs for tuberculosis using gamma interferon gene-disrupted mice. Antimicrob. Agents Chemother. 47:783-785.
    • Lenaerts, A. J., V. Gruppo, J. V. Brooks, and I. M. Orme. 2003. Rapid in vivo screening of experimental drugs for tuberculosis using gamma interferon gene-disrupted mice. Antimicrob. Agents Chemother. 47:783-785.
  • 12
    • 19544364888 scopus 로고    scopus 로고
    • Lenaerts, A. J., V. Gruppo, K. S. Marietta, C. M. Johnson, D. K. Driscoll, N. M. Tompkins, J. D. Rose, R. C. Reynolds, and I. M. Orme. 2005. Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models. Antimicrob. Agents Chemother. 49:2294-2301.
    • Lenaerts, A. J., V. Gruppo, K. S. Marietta, C. M. Johnson, D. K. Driscoll, N. M. Tompkins, J. D. Rose, R. C. Reynolds, and I. M. Orme. 2005. Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models. Antimicrob. Agents Chemother. 49:2294-2301.
  • 13
  • 14
    • 0033743936 scopus 로고    scopus 로고
    • Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazidrifampin therapy in a mouse tuberculosis model
    • Lenaerts, A. M., S. E. Chase, and M. H. Cynamon. 2000. Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazidrifampin therapy in a mouse tuberculosis model. Antimicrob. Agents Chemother. 44:3167-3168.
    • (2000) Antimicrob. Agents Chemother , vol.44 , pp. 3167-3168
    • Lenaerts, A.M.1    Chase, S.E.2    Cynamon, M.H.3
  • 15
    • 4644247782 scopus 로고    scopus 로고
    • Microbiology. Noninherited resistance to antibiotics
    • Levin, B. R. 2004. Microbiology. Noninherited resistance to antibiotics. Science 305:1578-1579.
    • (2004) Science , vol.305 , pp. 1578-1579
    • Levin, B.R.1
  • 16
    • 84960961533 scopus 로고
    • The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug
    • McCune, R. J., W. McDermott, and R. Tompsett. 1956. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J. Exp. Med. 104:763-802.
    • (1956) J. Exp. Med , vol.104 , pp. 763-802
    • McCune, R.J.1    McDermott, W.2    Tompsett, R.3
  • 17
    • 0000164959 scopus 로고
    • Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy
    • McCune, R. J., and R. Tompsett. 1956. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J. Exp. Med. 104:737-762.
    • (1956) J. Exp. Med , vol.104 , pp. 737-762
    • McCune, R.J.1    Tompsett, R.2
  • 18
    • 0013888783 scopus 로고
    • Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues
    • McCune, R. M., F. M. Feldmann, H. P. Lambert, and W. McDermott. 1966. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J. Exp. Med. 123:445-468.
    • (1966) J. Exp. Med , vol.123 , pp. 445-468
    • McCune, R.M.1    Feldmann, F.M.2    Lambert, H.P.3    McDermott, W.4
  • 19
    • 0013891278 scopus 로고
    • Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli
    • McCune, R. M., F. M. Feldmann, and W. McDermott. 1966. Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli. J. Exp. Med. 123:469-486.
    • (1966) J. Exp. Med , vol.123 , pp. 469-486
    • McCune, R.M.1    Feldmann, F.M.2    McDermott, W.3
  • 20
    • 2442685844 scopus 로고    scopus 로고
    • The search for new sterilizing anti-tuberculosis drugs
    • Mitchison, D. A. 2004. The search for new sterilizing anti-tuberculosis drugs. Front. Biosci. 9:1059-1072.
    • (2004) Front. Biosci , vol.9 , pp. 1059-1072
    • Mitchison, D.A.1
  • 21
    • 0032910406 scopus 로고    scopus 로고
    • Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis
    • Miyazaki, E., M. Miyazaki, J. M. Chen, R. E. Chaisson, and W. R. Bishai. 1999. Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis. Antimicrob. Agents Chemother. 43:85-89.
    • (1999) Antimicrob. Agents Chemother , vol.43 , pp. 85-89
    • Miyazaki, E.1    Miyazaki, M.2    Chen, J.M.3    Chaisson, R.E.4    Bishai, W.R.5
  • 23
    • 0032794697 scopus 로고    scopus 로고
    • Reactivation of latent tuberculosis: Variations on the Cornell murine model
    • Scanga, C. 1999. Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect. Immun. 67:4531-4538.
    • (1999) Infect. Immun , vol.67 , pp. 4531-4538
    • Scanga, C.1
  • 24
    • 0022745345 scopus 로고
    • Phenotypic tolerance: The search for beta-lactam antibiotics that kill nongrowing bacteria
    • Tuomanen, E. 1986. Phenotypic tolerance: the search for beta-lactam antibiotics that kill nongrowing bacteria. Rev. Infect. Dis. 8(Suppl. 3):S279-S291.
    • (1986) Rev. Infect. Dis , vol.8 , Issue.SUPPL. 3
    • Tuomanen, E.1
  • 26
    • 0034780485 scopus 로고    scopus 로고
    • Nonreplicating persistence of Mycobacterium tuberculosis
    • Wayne, L. G., and C. D. Sohaskey. 2001. Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55:139-163.
    • (2001) Annu. Rev. Microbiol , vol.55 , pp. 139-163
    • Wayne, L.G.1    Sohaskey, C.D.2
  • 27
    • 0029976980 scopus 로고    scopus 로고
    • An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence
    • Wayne, L. G., and L. G. Hayes. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64:2062-2069.
    • (1996) Infect. Immun , vol.64 , pp. 2062-2069
    • Wayne, L.G.1    Hayes, L.G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.